Wolwo Bio-Pharmaceutical Says 'Certain Percentage' of Trial Participants for Fungal Drug Showed Delayed Response in Phase 1 Trial

MT Newswires Live09-25

A "certain percentage" of participants in Zhejiang Wolwo Bio-Pharmaceutical's (SHE:300357) phase 1 clinical trial for its Aspergillus fumigatus prick solution showed a delayed reaction to the drug, according to a Thursday disclosure to the Shenzhen bourse.

Participants' delayed reaction to the drug suggests a "potential association with the fungal nature of Aspergillus fumigatus," the filing said.

Researchers are suggesting more optimal strategies to reduced the delayed reactions to the drug, the drug company said.

The drug showed a favorable safety profile within the established dose range of between 55 dosage units per milliliter and 495,000 dosage units per milliliter, the filing said.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2570098982?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-25 17:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2570098982","market":"sh","top_or_hot":-1,"title":"Wolwo Bio-Pharmaceutical Says 'Certain Percentage' of Trial Participants for Fungal Drug Showed Delayed Response in Phase 1 Trial","media":"MT Newswires Live","content":"<html><body><p> A \"certain percentage\" of participants in <a href=\"https://laohu8.com/S/300357\">Zhejiang Wolwo Bio-</a>Pharmaceutical's (SHE:300357) phase 1 clinical trial for its Aspergillus fumigatus prick solution showed a delayed reaction to the drug, according to a Thursday disclosure to the Shenzhen bourse.</p><p>Participants' delayed reaction to the drug suggests a \"potential association with the fungal nature of Aspergillus fumigatus,\" the filing said.</p><p>Researchers are suggesting more optimal strategies to reduced the delayed reactions to the drug, the drug company said.</p><p>The drug showed a favorable safety profile within the established dose range of between 55 dosage units per milliliter and 495,000 dosage units per milliliter, the filing said.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wolwo Bio-Pharmaceutical Says 'Certain Percentage' of Trial Participants for Fungal Drug Showed Delayed Response in Phase 1 Trial</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWolwo Bio-Pharmaceutical Says 'Certain Percentage' of Trial Participants for Fungal Drug Showed Delayed Response in Phase 1 Trial\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-09-25 17:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> A \"certain percentage\" of participants in <a href=\"https://laohu8.com/S/300357\">Zhejiang Wolwo Bio-</a>Pharmaceutical's (SHE:300357) phase 1 clinical trial for its Aspergillus fumigatus prick solution showed a delayed reaction to the drug, according to a Thursday disclosure to the Shenzhen bourse.</p><p>Participants' delayed reaction to the drug suggests a \"potential association with the fungal nature of Aspergillus fumigatus,\" the filing said.</p><p>Researchers are suggesting more optimal strategies to reduced the delayed reactions to the drug, the drug company said.</p><p>The drug showed a favorable safety profile within the established dose range of between 55 dosage units per milliliter and 495,000 dosage units per milliliter, the filing said.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"300357","symbol_name":"我武生物","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2570098982","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2570098982","pubTimestamp":1758793659,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"A \"certain percentage\" of participants in Zhejiang Wolwo Bio-Pharmaceutical's (SHE:300357) phase 1 clinical trial for its Aspergillus fumigatus prick solution showed a delayed reaction to the drug, ac","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"300357":"我武生物","BK0239":"医药制造","BK0028":"国家队"},"translate_title":"Wolwo Bio-Pharmaceutical表示，“一定比例”的真菌药物试验参与者在一期试验中表现出延迟反应","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300357":0.9},"content_text":"A \"certain percentage\" of participants in Zhejiang Wolwo Bio-Pharmaceutical's (SHE:300357) phase 1 clinical trial for its Aspergillus fumigatus prick solution showed a delayed reaction to the drug, according to a Thursday disclosure to the Shenzhen bourse.Participants' delayed reaction to the drug suggests a \"potential association with the fungal nature of Aspergillus fumigatus,\" the filing said.Researchers are suggesting more optimal strategies to reduced the delayed reactions to the drug, the drug company said.The drug showed a favorable safety profile within the established dose range of between 55 dosage units per milliliter and 495,000 dosage units per milliliter, the filing said.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2570098982","isCrawlerRequest":true}